Navigation Links
Patient Advocate Foundation Announces Additional Support for Co-Pay Relief Program Serving Multiple Myeloma Patients
Date:11/12/2009

Co-Pay Relief Program Provides Direct Financial Support for Pharmaceutical Co-Payments to Insured Patients in Medical and Financial Need

WASHINGTON, Nov. 12 /PRNewswire-USNewswire/ -- Patient Advocate Foundation (PAF) -- a national non-profit organization that seeks to safeguard patients through effective mediation assuring access to care, maintenance of employment and preservation of their financial stability relative to their diagnosis of life threatening or debilitating diseases -- is pleased to announce that it has received additional funding support for serving patients with multiple myeloma through its Co-Pay Relief Program (CPR).

PAF's Co-Pay Relief Program provides direct financial support for pharmaceutical co-payments to insured patients, including Medicare Part D beneficiaries, who financially and medically qualify. Since the program's inception in April 2004, CPR distributed more than $50 million in assistance to over 25,000 patients who were unable to afford their pharmaceutical co-payments.

"Patient Advocate Foundation is committed to improving the quality of life of patients facing medical and financial hardship through our professional case management and Co-Pay Relief services. We are thrilled to announce additional funding for our Co-Pay Relief Program, which will allow us to offer financial assistance to a larger number of Multiple Myeloma patients across the nation," said Nancy Davenport-Ennis, Founder and CEO of PAF. "A cancer diagnosis can be the most overwhelming experience a person may ever face in his or her lifetime. Coupled with high-cost pharmaceutical co-pay expenses, the journey can become significantly more challenging to manage -- so we are particularly pleased to be able to offer assistance to more patients."

"We are so pleased that the Patient Advocate Foundation was able to secure this additional funding for Multiple Myeloma patients. Through PAF's Co-Pay Relief Program, this funding will help Multiple Myeloma patients to better utilize their healthcare coverage, which will lead to more thorough management of their disease," said Anne Quinn Young, MPH, Director of Programs, Multiple Myeloma Research Foundation.

Multiple myeloma is a cancer of the plasma cell, an important part of the immune system that produces antibodies to help fight infection and disease.

Patient Advocate Foundation and its companion organization, the National Patient Advocate Foundation (NPAF), were founded on the principle that health care is a basic human need and shared social responsibility. Annually, PAF receives thousands of contacts requesting information and assistance via their toll-free hotline as well as online, with complete direct, sustained case management services provided to patients from all fifty states free of charge. For more information about PAF, visit www.patientadvocate.org or call toll free (800) 532-5274. For more information about PAF's Co-Pay Relief Program visit www.copays.org or call toll free (866) 512-3861.

SOURCE Patient Advocate Foundation


'/>"/>
SOURCE Patient Advocate Foundation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Leukemia Drug May Help Some Ovarian Cancer Patients
2. Frost & Sullivan to Hold Analyst Briefing on the European Neurophysiological Monitoring Market, the Golden Standard in Patient Safety
3. Neurologists Receive New Patient Education Resources from Vivacare for Epilepsy Awareness Month
4. Local Neurosurgeon Co-Authors National Treatment Guidelines for Brain Tumor Patients
5. Drugs to treat anemia in cancer patients linked to thromboembolism
6. Men leave: Separation and divorce far more common when the wife is the patient
7. The Time is Now for Better Pain Care for Patients - Physician Leaders from Across Medicine Conclude from a Closed-Door Pain Summit
8. Some chest pain patients wait longer than 10 minutes to see ER physician
9. Doctors Spending More Time Now With Patients
10. Physician bias might keep life-saving transplants from black and Hispanic patients
11. Austin Cosmetic Dentist Offers $15,000 Worth of Dental Work in Most Interesting Patient in the World Video Contest
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... , ... "With 30 hand-drawn hand gesture animations, FCPX users can easily customize ... Pixel Film Studios. , ProHand Cartoon’s package transforms over 1,300 hand-drawn pictures into ... Simply select a ProHand generator and drag it above media or text in the ...
(Date:6/25/2016)... , ... June 25, 2016 , ... On Friday, June ... a Bronze Wellness at Work award to iHire in recognition of their exemplary accomplishments ... of the 7th annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott ...
(Date:6/24/2016)... ... 2016 , ... June 19, 2016 is World Sickle Cell Observance Day. In ... benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued ... Sickle Cell Disease (SCD) is a disorder of the red blood cells, which can ...
(Date:6/24/2016)... Francisco, CA (PRWEB) , ... June 24, 2016 ... ... CitiDent, is now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive ... self-ligating Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB ... Decision Making in Emergency Medicine conference in Ponte Vedra Beach, FL. The awards ... in Emergency Medicine Practice and Pediatric Emergency Medicine Practice. , “With ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Any dentist who has made an implant supported ... Many of them do not even offer this as a ... laboratory costs involved. And those who ARE able to offer ... high cost that the majority of today,s patients would not ... Zadeh , founder of Dental Evolutions Inc. and inventor of ...
(Date:6/23/2016)... June 23, 2016 Roche (SIX: RO, ROG; ... for its Elecsys BRAHMS PCT (procalcitonin) assay as a ... septic shock. With this clearance, Roche is the first ... integrated solution for sepsis risk assessment and management. ... infection and PCT levels in blood can aid clinicians ...
(Date:6/23/2016)... June 23, 2016 Research and Markets ... Issue 52" report to their offering. ... treatment creates a favourable commercial environment for MedImmune to enter. ... base that will serve to drive considerable growth for effective ... serve to cap sales considerably, but development is still in ...
Breaking Medicine Technology: